CRCM, Hopital Necker-Enfants Malades, INSERM U 845, Universite Parsi Descartes, 149 Rue de Sevres, Paris 75015, France.
J Cyst Fibros. 2010 Sep;9(5):323-9. doi: 10.1016/j.jcf.2010.04.008.
Successful implementation of newborn screening (NBS) for cystic fibrosis (CF) depends on robust protocols, good communication and appropriate management of recognised infants. In response to current varied practice, the ECFS Neonatal Screening Working Group developed a consensus on the early management of these infants using the Delphi methodology.
Following detailed literature review, statements were generated by a core group of experts and then assessed by a larger group using modified Delphi methodology.
Forty-one statements were written by the core group. Eighty-six CF specialists contributed to the modified Delphi process. During three rounds, extra statements were added and consensus achieved on 44 (one statement did not achieve consensus).
These statements will provide a framework for the management of screened infants in the first year of life. This process highlights the paucity of evidence on which to base management of these infants. To improve this situation, it is important that each infant with CF identified through NBS has opportunity to be included in a randomised controlled trial.
新生儿筛查(NBS)对囊性纤维化(CF)的成功实施取决于健全的方案、良好的沟通以及对确诊婴儿的适当管理。为了应对当前多样化的实践,ECFS 新生儿筛查工作组使用德尔菲方法就这些婴儿的早期管理达成了共识。
在详细的文献综述之后,由核心专家组编写陈述,然后使用改良德尔菲法由更大的专家组进行评估。
核心小组编写了 41 条陈述。86 名 CF 专家参与了改良德尔菲法的过程。在三轮投票中,添加了额外的陈述,并就 44 条陈述达成了共识(一条陈述未达成共识)。
这些陈述将为婴儿出生后第一年管理筛查出的婴儿提供框架。这一过程突出表明,在管理这些婴儿方面,几乎没有证据可循。为了改善这种情况,非常重要的是,通过 NBS 确定的每个 CF 婴儿都有机会被纳入随机对照试验。